EXONATE LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Wtl Moorfield Road Duxford Cambridge Cambridgeshire England CB22 4PS Copied!
Latest financial results as of 1 September 2025- Cash in bank
- £2.01m
- Current assets
- £2.53m
- Current creditors
- £6.18m
- Shareholders funds
- £-8.33m
View full financial accounts- Cash in bank
- £2.01m
- Current assets
- £2.53m
- Current creditors
- £6.18m
- Shareholders funds
- £-8.33m
- Company number
- 08803638 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 5 December 2024
Next statement due by 19 December 2025
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Latest company documents
| Date | Description |
|---|---|
| 20/12/2420 December 2024 | Confirmation statement made on 2024-12-05 with updates |
| 04/09/244 September 2024 | Full accounts made up to 2023-12-31 |
| 15/05/2415 May 2024 | Appointment of Dr Rafiq Hasan as a director on 2024-05-13 |
| 17/01/2417 January 2024 | Confirmation statement made on 2023-12-05 with updates |
| 31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
Contact details
- Phone Number
- 01223734710
- 01157840088
- [email protected]
- Website
- https://www.exonate.com/
More Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company